A detailed history of Envestnet Asset Management Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 18,341 shares of PRCT stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,341
Previous 10,652 72.18%
Holding current value
$1.63 Million
Previous $650,000 126.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$56.31 - $84.99 $432,967 - $653,488
7,689 Added 72.18%
18,341 $1.47 Million
Q2 2024

Aug 08, 2024

BUY
$45.73 - $69.19 $487,115 - $737,011
10,652 New
10,652 $650,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.97B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.